Publication Cover
Redox Report
Communications in Free Radical Research
Volume 17, 2012 - Issue 5
792
Views
10
CrossRef citations to date
0
Altmetric
Research articles

An experimental model of contact dermatitis: Evaluation of the oxidative profile of Wistar rats treated with free and nanoencapsulated clobetasol

, , , , , , , , , , , & show all
Pages 206-213 | Published online: 19 Jul 2013

References

  • Fyhrquist-Vanni N, Alenius H, Lauerma A. Contact dermatitis. Dermatol Clin 2007;25(4):613–23, x.
  • Slodownik D, Lee A, Nixon R. Irritant contact dermatitis: a review. Australas J Dermatol 2008;49(1):1–9; quiz 10–1.
  • Saint-Mezard P, Rosieres A, Krasteva M, Berard F, Dubois B, Kaiserlian D, et al. Allergic contact dermatitis. Eur J Dermatol 2004;14(5):284–95.
  • Lepoittevin JP, Leblond I. Hapten-peptide T cell interactions: molecular basis for the recognition of haptens by T lymphocytes. Eur J Dermatol 1997;7(3):151–4.
  • Asano Y, Makino T, Norisugi O, Shimizu T. Occupational cobalt induced systemic contact dermatitis. Eur J Dermatol 2009;19(2):166–7.
  • Nicolas JF, Testud F, Vocanson M. Sensibilisation versus tolerance dans l'eczema de contact. Ann Dermatol Venereol 2008;135:733–6.
  • Saloga J, Knop J, Kolde G. Ultrastructural cytochemical visualization of chromium in the skin of sensitized guinea pigs. Arch Dermatol Res 1988;280(4):214–9.
  • Krasteva M, Kehren J, Ducluzeau MT, Sayag M, Cacciapuoti M, Akiba H, et al. Contact dermatitis I. Pathophysiology of contact sensitivity. Eur J Dermatol 1999;9(1):65–77.
  • Wiedersberg S, Leopold CS, Guy RH. Bioavailability and bioequivalence of topical glucocorticoids. Eur J Pharm Biopharm 2008;68(3):453–66.
  • Gagliardi L, Orsi D, Giudice M, Gatta F, Porra R, Chimenti P, et al. Development of a tandem thin-layer chromatography-high-performance liquid chromatography method for the identification and determination of corticosteroids in cosmetic products. Analytica Chimica Acta 2002;457(2):187–98.
  • Reepmeyer J, Revelee L, Vidavsky I. Detection of clobetasol propionate as an undeclared steroid in zinc pyrithione formulations by high- performance liquid chromatography with rapid-scanning ultraviolet spectroscopy and mass spectrometry. J Chromatogr A 1998;828(1–2):239–46.
  • Hengge UR, Ruzicka T, Schwartz RA, Cork MJ. Adverse effects of topical glucocorticosteroids. J Am Acad Dermatol 2006;54(1):1–15; quiz 6–8.
  • Fang JY, Shen KL, Huang YB, Wu PC, Tsai YH. Evaluation of topical application of clobetasol 17-propionate from various cream bases. Drug Dev Ind Pharm 1999;25(1):7–14.
  • Honeywell-Nguyen P, Bouwstra J. Vesicles as a tool for transdermal and dermal delivery. Drug Discov Today, Technol 2005;2(1):67–74.
  • Ramon E, Alonso C, Coderch L, de la Maza A, Lopez O, Parra JL, et al. Liposomes as alternative vehicles for sun filter formulations. Drug Deliv 2005;12(2):83–8.
  • Tursilli R, Piel G, Delattre L, Scalia S. Solid lipid microparticles containing the sunscreen agent, octyl-dimethylaminobenzoate: effect of the vehicle. Eur J Pharm Biopharm 2007;66(3):483–7.
  • Muller RH, Radtke M, Wissing SA. Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) in cosmetic and dermatological preparations. Adv Drug Deliv Rev 2002;54( Suppl. 1):S131–55.
  • Alvarez-Roman R, Naik A, Kalia YN, Guy RH, Fessi H. Enhancement of topical delivery from biodegradable nanoparticles. Pharm Res 2004;21(10):1818–25.
  • Wissing SA, Muller RH. Solid lipid nanoparticles as carrier for sunscreens: in vitro release and in vivo skin penetration. J Control Release 2002;81(3):225–33.
  • Alvarez-Roman R, Barre G, Guy RH, Fessi H. Biodegradable polymer nanocapsules containing a sunscreen agent: preparation and photoprotection. Eur J Pharm Biopharm 2001;52(2):191–5.
  • Perugini P, Simeoni S, Scalia S, Genta I, Modena T, Conti B, et al. Effect of nanoparticle encapsulation on the photostability of the sunscreen agent, 2-ethylhexyl-p-methoxycinnamate. Int J Pharm 2002;246(1–2):37–45.
  • Vettor M, Perugini P, Scalia S, Conti B, Genta I, Modena T, et al. Poly(D,L-lactide) nanoencapsulation to reduce photoinactivation of a sunscreen agent. Int J Cosmet Sci 2008;30(3):219–27.
  • Ourique AF, Melero A, Silva CD, Schaefer UF, Pohlmann AR, Guterres SS, et al. Improved photostability and reduced skin permeation of tretinoin: development of a semisolid nanomedicine. Eur J Pharm Biopharm 2011;79(1):95–101.
  • Alves MP, Scarrone AL, Santos M, Pohlmann AR, Guterres SS. Human skin penetration and distribution of nimesulide from hydrophilic gels containing nanocarriers. Int J Pharm 2007;341(1–2):215–20.
  • Marchiori ML, Lubini G, Dalla Nora G, Friedrich RB, Fontana MC, Ourique AF, et al. Hydrogel containing dexamethasone-loaded nanocapsules for cutaneous administration: preparation, characterization, and in vitro drug release study. Drug Dev Ind Pharm 2010;36(8):962–71.
  • Fontana MC, Coradini K, Guterres SS, Pohlmann AR, Beck RC. Nanoencapsulation as a way to control the release and to increase the photostability of clobetasol propionate: influence of the nanostructured system. J Biomed Nanotechnol 2009;5(3):254–63.
  • Mandawgade SD, Patravale VB. Development of SLNs from natural lipids: application to topical delivery of tretinoin. Int J Pharm 2008;363(1–2):132–8.
  • de Jalon EG, Blanco-Prieto MJ, Ygartua P, Santoyo S. PLGA microparticles: possible vehicles for topical drug delivery. Int J Pharm 2001;226(1–2):181–4.
  • Jenning V, Gysler A, Schafer-Korting M, Gohla SH. Vitamin A loaded solid lipid nanoparticles for topical use: occlusive properties and drug targeting to the upper skin. Eur J Pharm Biopharm 2000;49(3):211–8.
  • Luengo J, Weiss B, Schneider M, Ehlers A, Stracke F, Konig K, et al. Influence of nanoencapsulation on human skin transport of flufenamic acid. Skin Pharmacol Physiol 2006;19(4):190–7.
  • Siqueira NM, Contri RV, Paese K, Beck RC, Pohlmann AR, Guterres SS. Innovative sunscreen formulation based on benzophenone-3-loaded chitosan-coated polymeric nanocapsules. Skin Pharmacol Physiol 2011;24(3):166–74.
  • Fontana MC, Rezer JF, Coradini K, Leal DB, Beck RC. Improved efficacy in the treatment of contact dermatitis in rats by a dermatological nanomedicine containing clobetasol propionate. Eur J Pharm Biopharm 2011;79(2):241–249.
  • Fessi H, Devissaguet J, Puisieux F. Procédé de préparation de systèmes colloïdaux dispersibles d'une substance sous forme de nanocapsules. European Patent No 0274961-A1. 1988.
  • Tolosa EMC, Rodrigues CJ. Manual de técnicas para histologia normal e patológica. 2nd ed. São Paulo: Manole; 2003.
  • Ohkawa H, Ohishi N, Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 1979;95(2):351–8.
  • Levine RL, Garland D, Oliver CN, Amici A, Climent I, Lenz AG, et al. Determination of carbonyl content in oxidatively modified proteins. Methods Enzymol 1990;186:464–78.
  • Ellman GL. Tissue sulfhydryl groups. Arch Biochem Biophys 1959;82(1):70–7.
  • Aebi H. Catalase in vitro. Methods Enzymol 1984;105:121–6.
  • Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976;72:248–54.
  • Rao G, Murthy R. Evaluation of liposomal clobetasol propionate topical formulation for intra-dermal delivery. Indian J Pharm Sci 2000;62(6):459–62.
  • Lademann J, Richter H, Teichmann A, Otberg N, Blume-Peytavi U, Luengo J, et al. Nanoparticles–an efficient carrier for drug delivery into the hair follicles. Eur J Pharm Biopharm 2007;66(2):159–64.
  • ANVISA. Bula do profissional da saúde: bulário eletrônico da ANVISA. 2011.
  • Grotto D, Valentini J, Boeira S, Paniz C, Maria L, Vicentini J, et al. Avaliação da estabilidade do marcador plasmático do estresse oxidativo - malondialdeído. Química Nova 2008;31(2):275–9.
  • Jentzsch AM, Bachmann H, Furst P, Biesalski HK. Improved analysis of malondialdehyde in human body fluids. Free Radic Biol Med 1996;20(2):251–6.
  • Blauvelt A, Hwang ST, Udey MC. Allergic and immunologic diseases of the skin. J Allergy Clin Immunol 2003;111 (2 Suppl.):S560–70.
  • Watanabe H, Unger M, Tuvel B, Wang B, Sauder DN. Contact hypersensitivity: the mechanism of immune responses and T cell balance. J Interferon Cytokine Res 2002;22(4):407–12.
  • Cavani A, Albanesi C, Traidl C, Sebastiani S, Girolomoni G. Effector and regulatory T cells in allergic contact dermatitis. Trends Immunol 2001;22(3):118–20.
  • Fehr BS, Takashima A, Matsue H, Gerometta JS, Bergstresser PR, Cruz PD Contact sensitization induces proliferation of heterogeneous populations of hapten-specific T cells. Exp Dermatol 1994;3(4):189–97.
  • Fuchs J, Freisleben HJ, Packer L. Antioxidants in the skin. Boca Raton, Florida: CRC Press; 1992.
  • Picardo M, Zompetta C, Grandinetti M, Ameglio F, Santucci B, Faggioni A, et al. Paraphenylenediamine, a contact allergen, induces oxidative stress and ICAM-1 expression in human keratinocytes. Br J Dermatol 1996;134:681–5.
  • Sharkey P, Eddy DJ, Burrows D, McCaigue MD, Bell AL. A possible role for superoxide production in the pathogenesis of contact dermatitis. acta dermato-venereologica. 1990;71:156–9.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.